Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-05-11
2011-11-22
Solola, Taofiq A (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S272700
Reexamination Certificate
active
08063077
ABSTRACT:
The present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to intermediates used in making such compounds, pharmaceutical compositions containing such a compound, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
REFERENCES:
patent: 6376515 (2002-04-01), Zhu et al.
patent: 6423713 (2002-07-01), Anantanarayan et al.
patent: 6835739 (2004-12-01), Zhu et al.
patent: 6844367 (2005-01-01), Zhu et al.
patent: 6906063 (2005-06-01), Scarborough et al.
patent: 7022695 (2006-04-01), Zhu et al.
patent: 7157456 (2007-01-01), Straub et al.
patent: 7285565 (2007-10-01), Zhu et al.
patent: 7312235 (2007-12-01), Zhu et al.
patent: 7314874 (2008-01-01), Zhu et al.
patent: 7342013 (2008-03-01), Zhu et al.
patent: 7521470 (2009-04-01), Zhu et al.
patent: 7598276 (2009-10-01), Grant et al.
patent: 7696352 (2010-04-01), Zhu et al.
patent: 7727981 (2010-06-01), Zhu et al.
patent: 7727982 (2010-06-01), Zhu et al.
patent: 7763608 (2010-07-01), Song et al.
patent: 7767697 (2010-08-01), Song et al.
patent: 2003/0162690 (2003-08-01), Zhu et al.
patent: 2005/0171358 (2005-08-01), Shimozono et al.
patent: 2006/0100193 (2006-05-01), Zhu et al.
patent: 2007/0066615 (2007-03-01), Gerdes et al.
patent: 2007/0112039 (2007-05-01), Grant et al.
patent: 2007/0185092 (2007-08-01), Zhu et al.
patent: 2007/0259924 (2007-11-01), Song et al.
patent: 2008/0051578 (2008-02-01), Dahmann et al.
patent: 2008/0153876 (2008-06-01), Sinha et al.
patent: 2008/0241233 (2008-10-01), Sims et al.
patent: 2008/0254036 (2008-10-01), Sinha et al.
patent: 2008/0279845 (2008-11-01), Conley et al.
patent: 2008/0293704 (2008-11-01), Jia et al.
patent: 2009/0098119 (2009-04-01), Lu et al.
patent: 2009/0186810 (2009-07-01), Zwaal et al.
patent: 2009/0298806 (2009-12-01), Zhu et al.
patent: 2010/0063113 (2010-03-01), Grant et al.
patent: 2010/0125052 (2010-05-01), Lu et al.
patent: 2010/0197929 (2010-08-01), Scarborough et al.
patent: 2 453 846 (2003-01-01), None
patent: 2 653 666 (2007-12-01), None
patent: 10322469 (2004-12-01), None
patent: WO 99/07379 (1999-02-01), None
patent: WO 99/28317 (1999-06-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/21160 (2001-03-01), None
patent: WO 01/47919 (2001-07-01), None
patent: WO 01/64642 (2001-09-01), None
patent: WO 01/64643 (2001-09-01), None
patent: WO 01/91558 (2001-12-01), None
patent: WO 02/00651 (2002-01-01), None
patent: WO 02/079145 (2002-10-01), None
patent: WO 03/008395 (2003-01-01), None
patent: WO 03/059894 (2003-07-01), None
patent: WO 2004/101531 (2004-11-01), None
patent: WO 2004/101557 (2004-11-01), None
patent: WO 2004/106329 (2004-12-01), None
patent: WO 2005/032468 (2005-04-01), None
patent: WO 2005/034867 (2005-04-01), None
patent: WO 2005/035528 (2005-04-01), None
patent: WO 2005/082892 (2005-09-01), None
patent: WO 2006/002099 (2006-01-01), None
patent: WO 2007/007588 (2007-01-01), None
patent: WO 2007/025940 (2007-03-01), None
patent: WO 2007/056219 (2007-05-01), None
patent: WO 2007/112367 (2007-10-01), None
patent: WO 2007/131179 (2007-11-01), None
patent: WO 2007/137791 (2007-12-01), None
patent: WO 2008/057972 (2008-05-01), None
patent: WO 2008/073670 (2008-06-01), None
patent: WO 2008/086188 (2008-07-01), None
patent: WO 2008/086226 (2008-07-01), None
patent: WO 2008/121721 (2008-10-01), None
patent: WO 2008/127682 (2008-10-01), None
patent: WO 2008/137787 (2008-11-01), None
patent: WO 2009/042962 (2009-04-01), None
patent: PCT/US2010/029064 (2010-03-01), None
patent: WO 2010/056765 (2010-05-01), None
patent: PCT/US2010/042015 (2010-07-01), None
US 7,479,487, 01/2009, Zhu et al. (withdrawn)
U.S. Appl. No. 12/697,135, filed Jan. 29, 2010, Zhu et al.
U.S. Appl. No. 12/749,217, filed Mar. 29, 2010, Sinha et al.
U.S. Appl. No. 12/756,037, filed Apr. 7, 2010, Zhu et al.
U.S. Appl. No. 12/836,536, filed Jul. 14, 2010, Sinha et al.
Ostrovsky et al., “Analysis of Activity for Factory Xa Inhibitors Based on Monte Carlo Simulations”,J. Med. Chem.,p. 46, 5691-5699 (2003).
Roehrig et al., “Discovery of the Novel Antithrombotic Agent 5-Chloro-N-(((5S)-2-oxo-3[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazol idin-5-yl)methyl)thiophene 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor”,J. Med. Chem.,p. 48 (2005).
Jia Zhaozhong J.
Pandey Anjali
Scarborough Robert M.
Scarborough, legal representative Carroll
Song Yonghong
Foley & Lardner LLP
Millennium Pharmaceuticals Inc.
Solola Taofiq A
LandOfFree
Factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4306879